Sleeping Aids Market 2025

Sleeping Aids Market Definition

Sleeping aids refer to a range of products, devices and solutions designed to assist individuals in achieving better sleep quality, whether by addressing specific sleep disorders or enhancing overall restfulness. They are used to manage or alleviate sleep disturbances, such as insomnia or difficulty maintaining restful sleep. The sleeping aids market consists of sales, by entities (organizations, sole traders or partnerships), of sleeping aids that are commonly employed when individuals experience difficulties falling asleep, staying asleep or achieving restorative sleep. They are often used at home, in medical facilities such as hospitals or sleep laboratories and in specialized wellness centers.

Sleeping Aids Market Size

The global sleeping aids market reached a value of nearly $89,050.00 million in 2024, having grown at a compound annual growth rate (CAGR) of 4.55% since 2019. The market is expected to grow from $89,050.00 million in 2024 to $129, 298.58 million in 2029 at a rate of 7.74%. The market is then expected to grow at a CAGR of 7.66% from 2029 and reach $186,979.93 million in 2034. Growth in the historic period resulted from the increased prevalence of sleep disorders, rising disposable income, rise in demand for home healthcare and surge in mental health issues. Factors that negatively affected growth in the historic period were high costs of sleep management. Going forward, increasing prevalence of obesity, increasing healthcare expenditure, increasing aging population and growing penetration of e-commerce will drive the growth. Factor that could hinder the growth of the sleeping aids market in the future include economic instability.

Sleeping Aids Market Drivers

The key drivers of the sleeping aids market include: Rising Prevalence Of Obesity The rising prevalence of obesity is anticipated to drive the growth of the sleeping aids market in the future. The obese population refers to the group of individuals who have a body mass index of 30 or higher, indicating a level of body fat that significantly increases the risk of health problems. The obese population is rising due to a combination of factors, including increased consumption of high-calorie, processed foods, sedentary lifestyles, genetic predispositions and socioeconomic factors that limit access to healthy food and physical activity. The increasing obese population fuels demand for sleep aids, as obesity is closely linked to sleep disorders such as sleep apnea, which significantly disrupts sleep. Additionally, individuals with obesity often experience poor sleep quality due to factors such as difficulty breathing, leading to a higher reliance on sleep aids for better rest. For instance, in March 2024, according to a report published by the World Obesity Federation, a UK-based organization focused on combating obesity through research, advocacy and policy support, the number of adults living with obesity is projected to increase from 0.81 billion to 1.53 billion in 2035. Moreover, 79% of overweight and obese adults and 88% of overweight and obese children will reside in low- and middle-income countries (LMICs) by 2035. Therefore, the rising prevalence of obesity is fueling the growth of the sleeping aids market.

Sleeping Aids Market Restraints

The key restraints on the sleeping aids market include: Economic Instability Economic instability is expected to restrain the growth of the sleeping aids market during the forecast period. In times of economic downturn, consumers may prioritize essential needs over non-essential products like sleep aids, leading to reduced spending. Financial stress, job insecurity and rising living costs can also worsen sleep problems, while economic challenges could hinder manufacturers’ ability to offer affordable products, impacting overall market growth. For instance, in April 2024, according to a report by the World Bank, a US-based international financial institution, the global economy is expected to grow at 3.2% in 2024 and 2025, maintaining the pace of 2023. Growth in advanced economies will slightly accelerate, from 1.6% in 2023, to 1.7% in 2024 and 1.8% in 2025, while emerging market and developing economies will slow down modestly, from 4.3% in 2023, to 4.2% in both 2024 and 2025. The global growth forecast for five years from now is 3.1%, the lowest in decades. Therefore, economic instability is projected to negatively impact the growth of the sleeping aids market going forward.

Sleeping Aids Market Trends

Major trends shaping the sleeping aids market include: AI-Powered Personalization In The Sleeping Aids Market Companies in the sleeping aids market are increasingly focusing on offering personalized sleep solutions with smart devices, such as AI integration in sleep technology, that adjust based on user feedback and apps that provide detailed sleep analytics and advice for better sleep hygiene. This personalization helps cater to a wider range of individual sleep needs. AI integration in sleep technology involves using advanced algorithms and data analytics to personalize sleep solutions, track sleep patterns and provide actionable insights to improve sleep quality. For instance, in November 2024, The Sleep Company (TSC), an India-based mattress developer, unveiled the ‘SensAI Sleep Analyzer Pillow’, the world’s first AI (Artificial Intelligence)-powered SmartGRID pillow. The pillow aims to address the limitations of wearable sleep trackers. Equipped with a non-intrusive sleep tracker, the pillow features a sensor strip placed under the pillow and mattress to monitor sleep duration, quality (including deep and REM (Rapid Eye Movement) stages), body movements and restorative metrics, such as heart rate and breathing rate. All data is transmitted to an interactive app, offering users detailed insights, sleep scores and personalized recommendations to improve sleep health. The product range aims to educate users and help them optimize their sleep cycles for better well-being. Minimally Invasive Neurostimulation Devices As A Breakthrough In The Sleeping Aids Market Companies operating in sleeping aids market are enhancing their efforts towards minimally invasive neurostimulation devices, which have emerged due to their growing use in the sleeping aids market. These devices use electrical stimulation to target brain areas involved in sleep regulation, offering a non-pharmaceutical approach to managing insomnia. By being non-invasive, they provide a novel alternative to traditional sleep aids, appealing to those seeking safer, non-medication-based solutions for better sleep quality. For instance, in October 2024, Neurovalens, a UK-based medical technology provider, launched Modius Sleep, a minimally invasive neurostimulation device designed to treat chronic insomnia. It uses electrical vestibular nerve stimulation to influence brain areas controlling sleep patterns, without the need for surgery. The device, which is FDA (Food and drug administration)-cleared, has shown positive results, with 95% of trial participants reporting improved sleep after four weeks. It is available in the U.S. by prescription. It is a headset designed for home use, providing 30-minute sessions each evening that send safe electrical pulses to the vestibular nerve, which influences the hypothalamus and brainstem. This helps regulate circadian rhythm and sleep patterns, offering a therapeutic solution for chronic insomnia.

Opportunities And Recommendations In The Sleeping Aids Market

Opportunities – The top opportunities in the sleeping aids markets segmented by product will arise in the mattresses and pillows segment, which will gain $20,871.35 million of global annual sales by 2029. The top opportunities in the sleeping aids market segmented by indication will arise in the insomnia segment, which will gain $21,486.43 million of global annual sales by 2029. The top opportunities in the sleeping aids markets segmented by distribution channel will arise in the retail pharmacies segment, which will gain $14,015.02 million of global annual sales by 2029. The sleeping aids market size will gain the most in the USA at $11,006.68 million. Recommendations- To take advantage of the opportunities, The Business Research Company recommends the sleeping aids companies to focus on personalized sleep solutions with smart technology, focus on minimally invasive neurostimulation devices, focus on advanced technologies for personalized sleep solutions, focus on wellness solutions with natural ingredients, focus on capitalizing on the sleep apnea devices market, focus on the sleep apnea market, expand in emerging markets, focus on expanding strategic distribution channels, focus on optimizing competitive pricing strategies, focus on strengthening digital and content-driven promotion, focus on expanding healthcare and retail-based promotion and focus on the e-commerce market.